Endo (NDOI) Inventories, Raw Materials & Components : $95 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Endo Inventories, Raw Materials & Components?

Endo's inventories, raw materials & components for the quarter that ended in Dec. 2024 was $95 Mil.

Endo's quarterly raw materials increased from Apr. 2024 ($0 Mil) to Sep. 2024 ($96 Mil) but then declined from Sep. 2024 ($96 Mil) to Dec. 2024 ($95 Mil).

Endo's annual raw materials increased from Dec. 2022 ($0 Mil) to Dec. 2023 ($103 Mil) but then declined from Dec. 2023 ($103 Mil) to Dec. 2024 ($95 Mil).

Endo Inventories, Raw Materials & Components Historical Data

The historical data trend for Endo's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Inventories, Raw Materials & Components Chart

Endo Annual Data

Trend

Dec22

Dec23

Dec24

Inventories, Raw Materials & Components

103.34

94.76

Endo Quarterly Data
	Jun23	Sep23	Dec23	Apr24	Sep24	Dec24
Inventories, Raw Materials & Components	Get a 7-Day Free Trial			-	103.34	-	96.32	94.76

Endo Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Endo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Inventories, Raw Materials & Components

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Great Valley Parkway, Malvern, PA, USA, 19355

Website

https://www.endo.com

Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.